miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma

miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma

Background: Sorafenib constitutes a suitable treatment alternative for patients with advanced hepatocellular carcinoma (HCC) in whom atezolizumab + bevacizumab therapy is contraindicated. The aim of the study was the identification of a miRNA signature in liquid biopsy related to sorafenib response....

Full description

Bibliographic Details
Main Authors:	Patricia de la Cruz-Ojeda, Tobias Schmid, Loreto Boix, Manuela Moreno, Víctor Sapena, Juan M. Praena-Fernández, Francisco J. Castell, Juan Manuel Falcón-Pérez, María Reig, Bernhard Brüne, Miguel A. Gómez-Bravo, Álvaro Giráldez, Jordi Bruix, María T. Ferrer, Jordi Muntané
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Cells
Subjects:	extracellular vesicle hepatocellular carcinoma miRNA liquid biopsy Sorafenib
Online Access:	https://www.mdpi.com/2073-4409/11/17/2673

Similar Items

Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib
by: Michele Manganelli, et al.
Published: (2021-07-01)

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles
by: Alja Zottel, et al.
Published: (2020-11-01)

FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b
by: Elena Coccia, et al.
Published: (2020-12-01)

Activation of miR-101-3p/EZH2 pathway enhances sorafenib sensitivity of HepG2 cells
by: ZHANG Yueting, et al.
Published: (2020-11-01)

Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma
by: Xulei Huo, et al.
Published: (2023-11-01)

Physical Exercise Modulates miR-21-5p, miR-129-5p, miR-378-5p, and miR-188-5p Expression in Progenitor Cells Promoting Osteogenesis
by: Maria Teresa Valenti, et al.
Published: (2019-07-01)

Evaluation of the Expression of miR-486-3p, miR-548-3p, miR-561-5p and miR-509-5p in Tumor Biopsies of Patients with Oral Squamous Cell Carcinoma
by: Ata Garajei, et al.
Published: (2022-02-01)

Expression of miR-302a, miR-302b, miR-302c, miR-302d, miR-367, miR-371, miR-372, miR-373, miR-10b, miR-21 and miR-93 in cells of different histotypes of testicular germ cell tumors
by: M. S. Knyazeva, et al.
Published: (2022-03-01)

Association between Circulating MicroRNAs (miR-21-5p, miR-20a-5p, miR-29b-3p, miR-126-3p and miR-101-3p) and Chronic Allograft Dysfunction in Renal Transplant Recipients
by: Yu-Jen Chen, et al.
Published: (2022-10-01)

LncRNA NEAT1 modulates sorafenib resistance in hepatocellular carcinoma through regulating the miR-149-5p/AKT1 axis
by: Yuexiang Niu, et al.
Published: (2020-01-01)

Homocysteine metabolites inhibit autophagy by upregulating miR-21-5p, miR-155-5p, miR-216-5p, and miR-320c-3p in human vascular endothelial cells
by: Łukasz Witucki, et al.
Published: (2024-03-01)

Dysregulation of miR-21-5p, miR-93-5p, miR-200c-3p and miR-205-5p in Oral Squamous Cell Carcinoma: A Potential Biomarkers Panel?
by: Ovidiu Aghiorghiesei, et al.
Published: (2022-04-01)

Secreted miR-210-3p, miR-183-5p and miR-96-5p reduce sensitivity to docetaxel in prostate cancer cells
by: Maristella Canovai, et al.
Published: (2023-12-01)

Expression of miR-1-3p, miR-16-5p and miR-122-5p as Possible Risk Factors of Secondary Cardiovascular Events
by: Rafał Badacz, et al.
Published: (2021-08-01)

Bioinformatics analysis of the common targets of miR-223-3p, miR-122-5p, and miR-93-5p in polycystic ovarian syndrome
by: Liping Zou, et al.
Published: (2023-02-01)

Circulating MiR-17-5p, MiR-126-5p and MiR-145-3p Are Novel Biomarkers for Diagnosis of Acute Myocardial Infarction
by: Sheng Xue, et al.
Published: (2019-02-01)

miR-9-5p, miR-675-5p and miR-138-5p regulate Wnt signalling pathways and strontium-mediated osteogenesis
by: Tianhao Sun, et al.
Published: (2016-10-01)

miR-16-5p, miR-103-3p, and miR-27b-3p as Early Peripheral Biomarkers of Fetal Growth Restriction
by: Salvatore Tagliaferri, et al.
Published: (2021-03-01)

Post-transcriptional Regulation of PCSK9 by miR-191, miR-222, and miR-224
by: Parisa Naeli, et al.
Published: (2017-11-01)

MicroRNAs miR-142-5p, miR-150-5p, miR-320a-3p, and miR-4433b-5p in Serum and Tissue: Potential Biomarkers in Sporadic Breast Cancer
by: Tamyres Mingorance Carvalho, et al.
Published: (2022-06-01)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
by: Qiu Shuwei, et al.
Published: (2013-01-01)

miR-93, miR-373, and miR-17-5p Negatively Regulate the Expression of TBP2 in Lung Cancer
by: Ye Li, et al.
Published: (2020-04-01)

Circulating miR-16-5p, miR-92a-3p and miR-451a are biomarkers of lung cancer in Tunisian patients
by: Alya Boutabba, et al.
Published: (2024-04-01)

Characterization of miR-335-5p and miR-335-3p in human osteoarthritic tissues
by: Thomas G. Wilson, et al.
Published: (2023-06-01)

Clinical Significance of miR-183-3p and miR-182-5p in NSCLC and Their Correlation
by: Zhang T, et al.
Published: (2021-04-01)

Golgi phosphoprotein 3 promotes angiogenesis and sorafenib resistance in hepatocellular carcinoma via upregulating exosomal miR-494-3p
by: Ying Gao, et al.
Published: (2022-01-01)

Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma
by: Beáta Scholtz, et al.
Published: (2022-02-01)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
by: Sven H Loosen, et al.
Published: (2019-01-01)

Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer
by: Bin Song, et al.
Published: (2018-11-01)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
by: Miruna Nemecz, et al.
Published: (2023-09-01)

TNFα, IL-6, miR-103a-3p, miR-423-5p, miR-23a-3p, miR-15a-5p and miR-223-3p in the crevicular fluid of periodontopathic patients correlate with each other and at different stages of the disease
by: Erica Costantini, et al.
Published: (2023-01-01)

Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index
by: Sofía Elena Tesolato, et al.
Published: (2023-06-01)

Topographic Distribution of miRNAs (miR-30a, miR-223, miR-let-7a, miR-let-7f, miR-451, and miR-486) in the Plasma Extracellular Vesicles
by: Tatiana Petrova, et al.
Published: (2024-02-01)

The Similar Effects of miR-512-3p and miR-519a-2-5p on the Promotion of Hepatocellular Carcinoma: Different Tunes Sung With Equal Skill
by: Tao Rui, et al.
Published: (2020-08-01)

Normospermic Patients Infected With Ureaplasma parvum: Role of Dysregulated miR-122-5p, miR-34c-5, and miR-141-3p
by: Marilena Galdiero, et al.
Published: (2024-01-01)

Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease
by: Rachel E. Crossland, et al.
Published: (2021-03-01)

Plasma exosomal miR-320d, miR-4479, and miR-6763-5p as diagnostic biomarkers in epithelial ovarian cancer
by: Shiwen Wang, et al.
Published: (2022-12-01)

miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
by: Srinivas Chava, et al.
Published: (2020-01-01)

The Role of miR-375-3p and miR-200b-3p in Gastrointestinal Stromal Tumors
by: Ugne Gyvyte, et al.
Published: (2020-07-01)

miR-140-5p and miR-140-3p: Key Actors in Aging-Related Diseases?
by: Léa Toury, et al.
Published: (2022-09-01)